Effect of Intravenous Nalbuphine on Emergence Agitation
Primary Purpose
Postoperative Complications
Status
Completed
Phase
Phase 2
Locations
Egypt
Study Type
Interventional
Intervention
IV nalbuphine 0.1 mg/kg with induction of anesthesia.
IV nalbuphine 0.1 mg/kg at the end of surgery.
Sponsored by
About this trial
This is an interventional prevention trial for Postoperative Complications
Eligibility Criteria
Inclusion Criteria:
- Age: 3-8 years.
- American Society of Anesthesiologists (ASA) physical status I-II scheduled to undergo repair of rupture globe.
- Gender: both.
Exclusion Criteria:
- Parent refusal.
- History of developmental delay or mental retardation.
- Known hypersensitivity to any drug used in this study.
- Children with co-morbid conditions like congenital heart disease, respiratory pathology and central nervous system disorders.
Sites / Locations
- Assiut University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Group A
Group B
Arm Description
40 randomly allocated Patients undergoing repair of rupture globe will receive IV nalbuphine 0.1 mg/kg with induction of anesthesia.
40 randomly allocated Patients undergoing repair of rupture globe.will receive IV nalbuphine 0.1 mg/kg at the end of surgery just before discontinuation of anesthesia.
Outcomes
Primary Outcome Measures
The incidence of Emergence Agitation in children undergoing repair of rupture globe under general anesthesia
the Incidence of Emergence Agitation will be evaluated using Aono's four-point scale.
minimum score: 1
maximum score:4 Scores of one and two were considered as absence of EA, and scores of 3 and 4 were analyzed as presence of Emergence Agitation.
Calm
Not calm, but could be easily calmed
Moderately agitated or restless
Combative, excited, disoriente
Secondary Outcome Measures
The severity of Emergency Agitation
5- The severity of EA will be evaluated using the pediatric anesthesia emergence delirium scale A perfectly calm child scores 0 and extreme agitation corresponds to 20 points Agitation scores less than 10 will be interpreted as an absence of agitation, scores ≥ 10 will be regarded as presence of agitation, and scores ≥15 will be regarded as severe agitation
postoperative vomiting
Postoperative vomiting will be assessed using a numeric rank score
minimum score: 0
maximum score: 2 higher values represent a worse outcome and lowest values represent a better outcome 0 = no vomiting, 1 = vomited once, and 2 = vomited twice or more.
Postoperative sedation
Postoperative sedation will be assessed using sedation score described by Culebras et al (2001)
minimum score: 1
maximum score: 5 higher values represent a worse outcome and lowest values represent a better outcome 1. Awake and alert. 2. Sleeping but easily arouses to voice or light touch. 3. Arouses to loud voice or shaking. 4. Arouses with painful stimuli only. 5. Unarousable).
Postoperative FLACC Pain Score
Face, Legs, Activity, Cry, and Consolability (FLACC) pain score
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03470077
Brief Title
Effect of Intravenous Nalbuphine on Emergence Agitation
Official Title
Effect of Intravenous Nalbuphine on Emergence Agitation in Children Undergoing Repair of Rupture Globe
Study Type
Interventional
2. Study Status
Record Verification Date
September 2021
Overall Recruitment Status
Completed
Study Start Date
July 31, 2019 (Actual)
Primary Completion Date
September 30, 2020 (Actual)
Study Completion Date
December 1, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Assiut University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Our primary objective of this study is to compare the effect of administration of single dose of intravenous nalbuphine given with induction of anesthesia with intravenous nalbuphine given at the end of surgery on the incidence and severity of EA in children undergoing repair of rupture globe under general anesthesia.
The secondary outcomes will include FLACC score for postoperative pain assessment, hemodynamic variables, any complications as postoperative vomiting (POV) and sedation and parents' satisfaction score.
Detailed Description
Postoperative agitation, also referred to as emergence delirium is characterized by mental confusion, irritability, disorientation, inconsolable crying, and increased recovery time in the post anesthesia recovery room, increasing parents' concern and anxiety with respect to the clinical condition of their children . It can also lead to possible injury, damage to surgical dressings, lost intravenous catheters, disconnected cables and monitoring instruments, and source of dissatisfaction for parents, nurses, and others taking care of these children, and hence the children require extra nursing care and supplemental sedative and/or analgesic medications, which may delay patient discharge from hospital and are seven times more likely to have new-onset separation anxiety, apathy, and eating and sleep problems.
It is during the first 30 minutes after emergence that the greatest incidence of agitation is observed, and duration is generally limited and recovery occurs spontaneously. However, prolonged episodes of agitation lasting for up to 2 days have been described.
There is no definitive explanation for emergence agitation (EA). Many different causes have been suggested, such as rapid return of consciousness in an unfamiliar environment, the presence of pain (wounds, sore throat, and bladder distension), stressful induction, airway obstruction, a noisy environment, the duration of anesthesia, the child's personality, anesthetic premedication and the anesthetic technique used.
While its pathogenesis remains unclear, previous studies reported that ENT (ear, nose, and throat) surgical procedures have a higher incidence of EA in both adults and children . Children undergoing strabismus surgery under sevoflurane anesthesia often experience EA and postoperative vomiting (POV) .
Multiple medications including ketamine, propofol, clonidine, midazolam and fentanyl have been used effectively to prevent EA. However, these medications may increase sedation after anesthesia, cause slow awakening, and in some cases are associated with undesirable side effects, such as nausea and vomiting.
Nalbuphine is a synthetic opioid κ-receptor agonist μ-receptor antagonist with onset of action occurring within 2-3 min following IV injection, duration of analgesia of 3-6 hours and plasma half-life of 5 hours. Its analgesic potency approximately equals to morphine with less effects on cardiovascular and respiratory system, i.e., nalbuphine causes less intensive and less frequent decrease in blood pressure and respiratory depression.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Complications
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
Patients will be randomly allocated into two groups of 40 patients each:
Group A: will receive IV nalbuphine 0.1 mg/kg with induction of anesthesia. Group B: will receive IV nalbuphine 0.1 mg/kg at the end of surgery just before discontinuation of anesthesia.
Masking
ParticipantInvestigator
Masking Description
The trial will be planned that neither the doctors (investigators) nor the patients' guardians or even children themselves will be aware of the group allocation and timing of drug received
Allocation
Randomized
Enrollment
80 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group A
Arm Type
Experimental
Arm Description
40 randomly allocated Patients undergoing repair of rupture globe will receive IV nalbuphine 0.1 mg/kg with induction of anesthesia.
Arm Title
Group B
Arm Type
Experimental
Arm Description
40 randomly allocated Patients undergoing repair of rupture globe.will receive IV nalbuphine 0.1 mg/kg at the end of surgery just before discontinuation of anesthesia.
Intervention Type
Drug
Intervention Name(s)
IV nalbuphine 0.1 mg/kg with induction of anesthesia.
Other Intervention Name(s)
nalufin
Intervention Description
Group A: 40 patients will receive IV nalbuphine 0.1 mg/kg with induction of anesthesia.
.
Intervention Type
Drug
Intervention Name(s)
IV nalbuphine 0.1 mg/kg at the end of surgery.
Other Intervention Name(s)
nalufin
Intervention Description
Group B: 40 patients will receive IV nalbuphine 0.1 mg/kg at the end of surgery just before discontinuation of anesthesia.
Primary Outcome Measure Information:
Title
The incidence of Emergence Agitation in children undergoing repair of rupture globe under general anesthesia
Description
the Incidence of Emergence Agitation will be evaluated using Aono's four-point scale.
minimum score: 1
maximum score:4 Scores of one and two were considered as absence of EA, and scores of 3 and 4 were analyzed as presence of Emergence Agitation.
Calm
Not calm, but could be easily calmed
Moderately agitated or restless
Combative, excited, disoriente
Time Frame
at the first 30 minutes after surgery
Secondary Outcome Measure Information:
Title
The severity of Emergency Agitation
Description
5- The severity of EA will be evaluated using the pediatric anesthesia emergence delirium scale A perfectly calm child scores 0 and extreme agitation corresponds to 20 points Agitation scores less than 10 will be interpreted as an absence of agitation, scores ≥ 10 will be regarded as presence of agitation, and scores ≥15 will be regarded as severe agitation
Time Frame
at the first 30 minutes after surgery
Title
postoperative vomiting
Description
Postoperative vomiting will be assessed using a numeric rank score
minimum score: 0
maximum score: 2 higher values represent a worse outcome and lowest values represent a better outcome 0 = no vomiting, 1 = vomited once, and 2 = vomited twice or more.
Time Frame
first 48 hours after surgery
Title
Postoperative sedation
Description
Postoperative sedation will be assessed using sedation score described by Culebras et al (2001)
minimum score: 1
maximum score: 5 higher values represent a worse outcome and lowest values represent a better outcome 1. Awake and alert. 2. Sleeping but easily arouses to voice or light touch. 3. Arouses to loud voice or shaking. 4. Arouses with painful stimuli only. 5. Unarousable).
Time Frame
first 48 hours after surgery
Title
Postoperative FLACC Pain Score
Description
Face, Legs, Activity, Cry, and Consolability (FLACC) pain score
Time Frame
first 24 hours after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age: 3-8 years.
American Society of Anesthesiologists (ASA) physical status I-II scheduled to undergo repair of rupture globe.
Gender: both.
Exclusion Criteria:
Parent refusal.
History of developmental delay or mental retardation.
Known hypersensitivity to any drug used in this study.
Children with co-morbid conditions like congenital heart disease, respiratory pathology and central nervous system disorders.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hamdy Abbas, Professor
Organizational Affiliation
Assiut University
Official's Role
Study Director
Facility Information:
Facility Name
Assiut University Hospital
City
Assiut
ZIP/Postal Code
71515
Country
Egypt
12. IPD Sharing Statement
Citations:
PubMed Identifier
17179249
Citation
Vlajkovic GP, Sindjelic RP. Emergence delirium in children: many questions, few answers. Anesth Analg. 2007 Jan;104(1):84-91. doi: 10.1213/01.ane.0000250914.91881.a8.
Results Reference
background
PubMed Identifier
9416712
Citation
Aono J, Ueda W, Mamiya K, Takimoto E, Manabe M. Greater incidence of delirium during recovery from sevoflurane anesthesia in preschool boys. Anesthesiology. 1997 Dec;87(6):1298-300. doi: 10.1097/00000542-199712000-00006.
Results Reference
background
PubMed Identifier
15114210
Citation
Sikich N, Lerman J. Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiology. 2004 May;100(5):1138-45. doi: 10.1097/00000542-200405000-00015.
Results Reference
background
PubMed Identifier
7561228
Citation
Taddio A, Nulman I, Koren BS, Stevens B, Koren G. A revised measure of acute pain in infants. J Pain Symptom Manage. 1995 Aug;10(6):456-63. doi: 10.1016/0885-3924(95)00058-7.
Results Reference
background
PubMed Identifier
23344921
Citation
Chen JY, Jia JE, Liu TJ, Qin MJ, Li WX. Comparison of the effects of dexmedetomidine, ketamine, and placebo on emergence agitation after strabismus surgery in children. Can J Anaesth. 2013 Apr;60(4):385-92. doi: 10.1007/s12630-013-9886-x. Epub 2013 Jan 24.
Results Reference
background
Learn more about this trial
Effect of Intravenous Nalbuphine on Emergence Agitation
We'll reach out to this number within 24 hrs